Vertex Pharmaceuticals Inc (NAS:VRTX)
$ 493.49 3.49 (0.71%) Market Cap: 127.09 Bil Enterprise Value: 121.33 Bil PE Ratio: 0 PB Ratio: 8.14 GF Score: 93/100

Q2 2021 Vertex Pharmaceuticals Inc Earnings Call Transcript

Jul 29, 2021 / 09:30PM GMT
Release Date Price: $200.38 (-0.92%)
Operator

Good day, and thank you for standing by. Welcome to the Vertex Pharmaceuticals Q2 2021 Conference Call. (Operator Instructions) Please be advised that today's conference call is being recorded. (Operator Instructions)

At this time, I'd like to turn the call over to your host to Mr. Michael Partridge. Sir, you may begin.

Michael Partridge
Vertex Pharmaceuticals Incorporated - SVP of IR

Good evening. This is Michael Partridge. Welcome to the Vertex Second Quarter 2021 Financial Results Conference Call. Making prepared remarks on the call tonight, we have Dr. Reshma Kewalramani, Vertex' CEO and President; Stuart Arbuckle, Chief Commercial and Operations Officer; and Charlie Wagner, Chief Financial Officer.

We recommend that you access the webcast slides on our website as you listen to this call. This call is being recorded. A replay will be available on our website.

We will make forward-looking statements on this call that are subject to the risks and uncertainties discussed in detail in today's press release and in our filings with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot